proxyvotesnow.com

Home › Companies › Integra LifeSciences Holdings Corporation › 2025-2026

Integra LifeSciences Holdings Corporation 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Integra LifeSciences Holdings Corporation’s Form 8-K, filed 2026-05-08 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 13Reported items
  • 256Asset managers
  • 2,920Fund votes
  • 2026-05-07Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Integra LifeSciences Holdings Corporation in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Integra LifeSciences Holdings Corporation

These tallies are Integra LifeSciences Holdings Corporation’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-08 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Integra LifeSciences Holdings Corporation — official shareholder meeting results, meeting held 2026-05-07
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Keith Bradley, Ph.D. 64,904,3724,378,28833,540 --3,918,311 Majority: yes
Elect Director: Shaundra D. Clay 68,996,420286,93932,841 --3,918,311 Majority: yes
Elect Director: Stuart M. Essig, Ph.D. 68,172,6701,113,68829,842 --3,918,311 Majority: yes
Elect Director: Jeffrey A. Graves, Ph.D. 65,841,9173,442,84431,439 --3,918,311 Majority: yes
Elect Director: Barbara B. Hill 62,241,2037,042,47532,522 --3,918,311 Majority: yes
Elect Director: Renee W. Lo 68,619,639664,39032,171 --3,918,311 Majority: yes
Elect Director: Christian S. Schade 68,247,3571,037,01031,833 --3,918,311 Majority: yes
Item No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers, by the votes set forth below. 68,472,769732,580110,851 --3,918,311 Majority: yes
Item No. 4: The stockholders approved the Plan Amendment, by the votes set forth below: 68,005,4331,269,23141,536 --3,918,311 Majority: yes

Source: Integra LifeSciences Holdings Corporation, Form 8-K, filed with the SEC on 2026-05-08 — read the filing on EDGAR.

How asset managers voted at the Integra LifeSciences Holdings Corporation 2025-2026 meeting

Each item below shows how the 256 asset managers that disclosed a Integra LifeSciences Holdings Corporation vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Integra LifeSciences Holdings Corporation’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the compensation of our named executive officers.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Combines 8 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 68,472,769AGAINST: 732,580

Integra LifeSciences Holdings Corporation’s own tally for this item (“Item No. 3: The stockholders approved, on an advisory, non-binding basis, the compensation of the Company's named executive officers, by the votes set forth below.”): 68,472,769 for, 732,580 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 88% for, 1.0% against (89% of the company cast a for/against vote).

The 255 asset managers below cast 99% of the shares they voted on this item FOR (65,984,151 for, 674,293 against).

FOR 99%
FOR: 65,984,151 (98.9%)AGAINST: 674,293 (1.0%)ABSTAIN: 81,330 (0.1%)
Largest asset managers voting on “To approve, on a non-binding advisory basis, the compensation of our named executive officers.” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock9,769,6960 00For
Vanguard7,659,2762 00For
Invesco7,412,0420 00For
Rubric Capital Management LP3,983,2600 00For
FULLER & THALER ASSET MANAGEMENT, INC.3,428,0120 00For
PARADIGM CAPITAL MANAGEMENT INC/NY3,199,8200 00For
Charles Schwab3,081,9800 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
BOSTON MANAGEMENT & RESEARCH2,741,3450 00For
State Street2,218,86614,748 00For
Neuberger Berman2,211,1900 00For
GEODE CAPITAL MANAGEMENT, LLC1,481,4360 00For
Fidelity1,281,7770 00For
Dimensional1,241,4950 00For
Wellington1,201,9330 00For
Invenomic Capital Management LP966,9580 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Northern Trust607,1613,452 00For
SYSTEMATIC FINANCIAL MANAGEMENT LP531,6730 00For
Goldman Sachs466,9130 00For
CANADA PENSION PLAN INVESTMENT BOARD434,9000 00For
Victory Capital394,3250 00For
PRINCIPAL GLOBAL INVESTORS328,8420 00For
Leeward Investments, LLC - MA294,6450 00For

Showing the 25 largest of 255 asset managers. See all 255 in the interactive database.

2. To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Equity Incentive Plan.

OTHER SOCIAL ISSUES

Combines 3 wordings of this item as funds reported it.

99.6% fund support · no official result

FOR 99.6%

The 73 asset managers below cast 99.6% of the shares they voted on this item FOR (30,648,918 for, 95,208 against).

FOR: 30,648,918 (99.6%)AGAINST: 95,208 (0.3%)ABSTAIN: 19,330 (0.1%)
Largest asset managers voting on “To approve Amendment No. 3 to the Integra LifeSciences Holdings Corporation Fifth Amended and Restated 2003 Eq” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,027,5763 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,43557 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 73 asset managers. See all 73 in the interactive database.

3. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Stuart M. Essig

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 68,172,670AGAINST: 1,113,688

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Stuart M. Essig, Ph.D.”): 68,172,670 for, 1,113,688 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 88% for, 1% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.5% of the shares they voted on this item FOR (30,612,168 for, 139,021 against).

FOR 99.4%
FOR: 30,612,168 (99.5%)AGAINST: 139,021 (0.5%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3879,193 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle0105,148 00Against

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

4. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Jeffrey A. Graves

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

95% Majority: yes · of votes cast

FOR 95%
FOR: 65,841,917AGAINST: 3,442,844

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Jeffrey A. Graves, Ph.D.”): 65,841,917 for, 3,442,844 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.8% of the shares they voted on this item FOR (30,700,521 for, 51,827 against).

FOR 99.7%
FOR: 30,700,521 (99.8%)AGAINST: 51,827 (0.2%)ABSTAIN: 19,330 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,027,56514 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,4920 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

5. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Barbara B. Hill

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 62,241,203AGAINST: 7,042,475

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Barbara B. Hill”): 62,241,203 for, 7,042,475 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 80% for, 9% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 95% of the shares they voted on this item FOR (29,367,021 for, 1,384,168 against).

FOR 95%
FOR: 29,367,021 (95.4%)AGAINST: 1,384,168 (4.5%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,013,70313,877 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street2,345990,988 1,1590Against
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA0153,428 00Against
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle0105,148 00Against

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

6. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Renee W. Lo

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.0% Majority: yes · of votes cast

FOR 99.0%
FOR: 68,619,639AGAINST: 664,390

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Renee W. Lo”): 68,619,639 for, 664,390 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 88% for, 0.9% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.9% of the shares they voted on this item FOR (30,752,977 for, 28,212 against).

FOR 99.8%
FOR: 30,752,977 (99.8%)AGAINST: 28,212 (0.1%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3889,192 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,3330 1,1590For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

7. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Christian S. Schade

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 68,247,357AGAINST: 1,037,010

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Christian S. Schade”): 68,247,357 for, 1,037,010 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 88% for, 1% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.9% of the shares they voted on this item FOR (30,752,919 for, 28,270 against).

FOR 99.8%
FOR: 30,752,919 (99.8%)AGAINST: 28,270 (0.1%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3879,193 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

8. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Keith Bradley

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

94% Majority: yes · of votes cast

FOR 94%
FOR: 64,904,372AGAINST: 4,378,288

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Keith Bradley, Ph.D.”): 64,904,372 for, 4,378,288 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 83% for, 6% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.3% of the shares they voted on this item FOR (30,505,945 for, 185,244 against).

FOR 99.3%
FOR: 30,505,945 (99.3%)AGAINST: 185,244 (0.6%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3749,206 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,27557 1,1590For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle0105,148 00Against

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

9. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified: Shaundra D. Clay

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 68,996,420AGAINST: 286,939

Integra LifeSciences Holdings Corporation’s own tally for this item (“Elect Director: Shaundra D. Clay”): 68,996,420 for, 286,939 against, per its Form 8-K filed 2026-05-08 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 77,796,903 outstanding shares: 89% for, 0.4% against (89% of the company cast a for/against vote).

The 72 asset managers below cast 99.9% of the shares they voted on this item FOR (30,662,978 for, 28,211 against).

FOR 99.8%
FOR: 30,662,978 (99.8%)AGAINST: 28,211 (0.1%)ABSTAIN: 20,489 (0.1%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,018,3899,191 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street993,3330 1,1590For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 72 asset managers. See all 72 in the interactive database.

10. To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year 2026.

AUDIT-RELATED

Combines 3 wordings of this item as funds reported it.

99.8% fund support · no official result

FOR 99.7%

The 71 asset managers below cast 99.8% of the shares they voted on this item FOR (30,724,939 for, 56,889 against).

FOR: 30,724,939 (99.8%)AGAINST: 56,889 (0.2%)ABSTAIN: 19,330 (0.1%)
Largest asset managers voting on “To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public account” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock7,098,0020 00For
Vanguard7,022,9154,664 00For
Invesco3,477,6340 00For
UNDISCOVERED MANAGERS FUNDS2,890,8430 00For
Charles Schwab1,518,6690 00For
Fidelity1,276,3940 00For
Dimensional1,080,6140 00For
State Street994,43557 00For
PARADIGM FUNDS710,0000 00For
PIMCO619,0010 00For
Neuberger Berman560,1080 00For
Hartford271,2160 00For
Victory Capital196,0940 00For
Goldman Sachs192,3550 00For
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
TIAA153,4280 00For
Equitable152,5030 00For
Jackson National135,1520 00For
Transamerica134,6000 00For
American Century126,0800 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
Managed Portfolio Series124,4780 00For
QUANTITATIVE MASTER SERIES LLC107,5800 00For
Columbia Threadneedle105,1480 00For

Showing the 25 largest of 71 asset managers. See all 71 in the interactive database.

11. ELECTION OF DIRECTOR TO SERVE UNTIL THE NEXT ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DULY ELECTED AND QUALIFIED: MOJDEH POUL

DIRECTOR ELECTIONS

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.4%

The 18 asset managers below cast 100% of the shares they voted on this item FOR (3,537,685 for, 0 against).

FOR: 3,537,685 (99.5%)ABSTAIN: 19,511 (0.5%)
Largest asset managers voting on “ELECTION OF DIRECTOR TO SERVE UNTIL THE NEXT ANNUAL MEETING OF STOCKHOLDERS AND UNTIL THEIR SUCCESSORS ARE DUL” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Charles Schwab1,518,6690 00For
Neuberger Berman560,1080 00For
Vanguard456,2740 1810For
Hartford271,2160 00For
Transamerica134,6000 00For
NYLIM VP FUNDS TRUST125,5290 00For
SEI124,7610 00For
HUSSMAN INVESTMENT TRUST100,0000 00For
ADVISORS' INNER CIRCLE FUND89,6000 00For
Prudential/PGIM60,4500 00For
Morgan Stanley55,3440 00For
Global X30,8540 00For
Brighthouse00 19,3300Abstain
Venerable Variable Insurance Trust5,1960 00For
Vericimetry Funds3,3370 00For
Nationwide1,1980 00For
Advisors' Inner Circle Fund III3610 00For
NEW COVENANT FUNDS1880 00For

12. To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified. Mojdeh Poul

DIRECTOR ELECTIONS

100% fund support · no official result

ABSTAIN 98%

The 14 asset managers below cast 100% of the shares they voted on this item FOR (243,530 for, 0 against).

FOR: 243,530 (2.3%)ABSTAIN: 10,531,642 (97.7%)
Largest asset managers voting on “To elect eight directors of the Company to serve until the next annual meeting of stockholders and until their” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
BlackRock00 7,098,0020Abstain
UNDISCOVERED MANAGERS FUNDS00 2,890,8430Abstain
TRUST FOR PROFESSIONAL MANAGERS173,4980 00For
Jackson National00 135,1520Abstain
Managed Portfolio Series00 124,4780Abstain
QUANTITATIVE MASTER SERIES LLC00 107,5800Abstain
Bridge Builder Trust00 75,9230Abstain
TOUCHSTONE FUNDS GROUP TRUST00 52,0730Abstain
Northern Lights Fund Trust IV39,6540 00For
John Hancock00 25,8960Abstain
Allianz00 21,6950Abstain
NORTHERN LIGHTS FUND TRUST III18,6590 00For
EA Series Trust11,3410 00For
WILSHIRE MUTUAL FUNDS INC3780 00For

13. Elect Director Mojdeh Poul *Withdrawn Resolution*

DIRECTOR ELECTIONS

— fund support · no official result

ABSTAIN 45.3%NOT VOTED 35%12%

No shares were cast for or against this item by the managers below — every disclosed position was an abstention or was not voted.

ABSTAIN: 33,148 (45.3%)NOT VOTED: 25,457 (34.8%)UNKNOWN: 8,813 (12.0%)#N/A: 3,804 (5.2%)NON-VOTING BALLOT: 1,500 (2.0%)N/A: 520 (0.7%)
Largest asset managers voting on “Elect Director Mojdeh Poul *Withdrawn Resolution*” at Integra LifeSciences Holdings Corporation, 2025-2026
Asset managerForAgainst AbstainWithheldVote
Catholic Responsible Investments Funds00 33,1480Abstain
Brighthouse00 00Not Voted
Lincoln Financial00 00Not Voted
SA FUNDS INVESTMENT TRUST00 00Unknown
Strategy Shares00 00Unknown
Blackstone Alternative Investment Funds00 00Non-Voting Ballot
Empower00 00N/A

Largest Integra LifeSciences Holdings Corporation shareholders voting in 2025-2026

Ranked by the number of Integra LifeSciences Holdings Corporation shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 77,796,903 shares outstanding at the time of that meeting.

Top Integra LifeSciences Holdings Corporation shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1BlackRock 12.56%
2Vanguard 9.85%
3Invesco 9.53%
4Rubric Capital Management LP 5.12%
5FULLER & THALER ASSET MANAGEMENT, INC. 4.41%
6PARADIGM CAPITAL MANAGEMENT INC/NY 4.11%
7Charles Schwab 3.96%
8UNDISCOVERED MANAGERS FUNDS 3.72%
9BOSTON MANAGEMENT & RESEARCH 3.52%
10State Street 2.87%

Reported Integra LifeSciences Holdings Corporation ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Integra LifeSciences Holdings Corporation beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
BlackRock 13.26% 13F
Tru St Partnership LP and Provco Leasing Corporation 10.95% DEF14A
Rubric Capital Management LP 9.45% DEF14A
Vanguard Group 9.27% 13F
Morgan Stanley 4.95% 13F
Invesco 4.48% 13F
State Street 3.71% 13F
Dimensional Fund Advisors 3.57% 13F
Goldman Sachs 2.41% 13F
Stuart M. Essig, Ph.D. 2.29% DEF14A

Percentages above are of 77,796,903 shares outstanding, as reported by Integra LifeSciences Holdings Corporation on its Form 10-Q dated 2026-05-04 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Integra LifeSciences Holdings Corporation’s 10-Q dated 2026-05-04. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Integra LifeSciences Holdings Corporation's shareholder meeting held 2026-05-07, in the 2025-2026 proxy season, 256 asset managers reported how they voted in their SEC Form N-PX filings, covering 2,920 separate fund positions. Their filings are grouped here into 13 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — To approve, on a non-binding advisory basis, the compensation of our named executive officers. — FOR was 99% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: Integra LifeSciences Holdings Corporation's Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2026-05-08.

Integra LifeSciences Holdings Corporation proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).